Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Renal outcomes in CVOTs: keep calm and carry on.
Muskiet MHA, van Baar MJB, Scholtes RA, van Raalte DH. Muskiet MHA, et al. Among authors: scholtes ra. Lancet Diabetes Endocrinol. 2018 Sep;6(9):674-676. doi: 10.1016/S2213-8587(18)30195-5. Epub 2018 Jun 21. Lancet Diabetes Endocrinol. 2018. PMID: 29937268 No abstract available.
Mineralocorticoid Antagonism and Diabetic Kidney Disease.
Lytvyn Y, Godoy LC, Scholtes RA, van Raalte DH, Cherney DZ. Lytvyn Y, et al. Among authors: scholtes ra. Curr Diab Rep. 2019 Jan 23;19(1):4. doi: 10.1007/s11892-019-1123-8. Curr Diab Rep. 2019. PMID: 30673886 Review.
The effects of dapagliflozin on cardio-renal risk factors in patients with type 2 diabetes with or without renin-angiotensin system inhibitor treatment: a post hoc analysis.
Scholtes RA, van Raalte DH, Correa-Rotter R, Toto RD, Heerspink HJL, Cain V, Sjöström CD, Sartipy P, Stefánsson BV. Scholtes RA, et al. Diabetes Obes Metab. 2020 Apr;22(4):549-556. doi: 10.1111/dom.13923. Epub 2019 Dec 14. Diabetes Obes Metab. 2020. PMID: 31742881 Free PMC article.
Natriuretic Effect of Two Weeks of Dapagliflozin Treatment in Patients With Type 2 Diabetes and Preserved Kidney Function During Standardized Sodium Intake: Results of the DAPASALT Trial.
Scholtes RA, Muskiet MHA, van Baar MJB, Hesp AC, Greasley PJ, Karlsson C, Hammarstedt A, Arya N, van Raalte DH, Heerspink HJL. Scholtes RA, et al. Diabetes Care. 2021 Feb;44(2):440-447. doi: 10.2337/dc20-2604. Epub 2020 Dec 14. Diabetes Care. 2021. PMID: 33318125 Free PMC article. Clinical Trial.
Effects of dapagliflozin on volume status and systemic haemodynamics in patients with chronic kidney disease without diabetes: Results from DAPASALT and DIAMOND.
Sen T, Scholtes R, Greasley PJ, Cherney DZI, Dekkers CCJ, Vervloet M, Danser AHJ, Barbour SJ, Karlsson C, Hammarstedt A, Li Q, Laverman GD, Bjornstad P, van Raalte DH, Heerspink HJL. Sen T, et al. Diabetes Obes Metab. 2022 Aug;24(8):1578-1587. doi: 10.1111/dom.14729. Epub 2022 Jun 1. Diabetes Obes Metab. 2022. PMID: 35478433 Free PMC article. Clinical Trial.
The Adaptive Renal Response for Volume Homeostasis During 2 Weeks of Dapagliflozin Treatment in People With Type 2 Diabetes and Preserved Renal Function on a Sodium-Controlled Diet.
Scholtes RA, Muskiet MHA, van Baar MJB, Hesp AC, Greasley PJ, Hammarstedt A, Karlsson C, Hallow KM, Danser AHJ, Heerspink HJL, van Raalte DH. Scholtes RA, et al. Kidney Int Rep. 2022 Mar 4;7(5):1084-1092. doi: 10.1016/j.ekir.2022.02.023. eCollection 2022 May. Kidney Int Rep. 2022. PMID: 35570989 Free PMC article.
13 results